Table 2.
Concordance between patient-declared vaccination coverage, specific immunoglobulins (IG) administration, and tetanic vaccination and the TQS test results.
TQS | p a | ||
---|---|---|---|
Positive (%) | Negative (%) | ||
Declaredvaccinationcoverage | |||
Male | |||
Yes | 26 (63.4) | 15 (36.6) | |
No | 5 (38.5) | 8 (61.5) | P = 0.041 |
Female | |||
Yes | 8 (27.6) | 21 (72.4) | |
No | 0 (-) | 7 (100) | P < 0.001 |
Total | |||
Yes | 34 (48.6) | 36 (51.4) | |
No | 5 (25.0) | 15 (75.0) | P < 0.001 |
IG administration | |||
Male | |||
Yes | 14 (7.1) | 184 (92.9) | |
No | 42 (60.9) | 27 (29.1) | P < 0.001 |
Female | |||
Yes | 6 (3.1) | 187 (96.9) | |
No | 11 (25.6) | 32 (74.4) | P < 0.001 |
Total | |||
Yes | 20 (5.1) | 371 (94.9) | |
No | 53 (47.3) | 59 (52.7) | P < 0.001 |
Tetanicvaccination | |||
Male | |||
Yes | 16 (7.7) | 191 (92.3) | |
No | 40 (67.8) | 19 (32.2) | P < 0.001 |
Female | |||
Yes | 8 (4.0) | 194 (96.0) | |
No | 9 (26.5) | 25 (73.5) | P < 0.001 |
Total | |||
Yes | 24 (32.9) | 385 (89.7) | |
No | 49 (67.1) | 44 (10.3) | P < 0.001 |
Reported p-values are obtained by McNemar test.